Tsuda Katsunori, Miyamoto Licht, Hamano Shuichi, Morimoto Yuri, Kangawa Yumi, Fukue Chika, Kagawa Yoko, Horinouchi Yuya, Xu Wenting, Ikeda Yasumasa, Tamaki Toshiaki, Tsuchiya Koichiro
Department of Medical Pharmacology, Institute of Biomedical Sciences, University of Tokushima Graduate School.
Department of Cell and Immunity Analytics, Institute of Biomedical Sciences, University of Tokushima Graduate School.
Biol Pharm Bull. 2018;41(4):555-563. doi: 10.1248/bpb.b17-00855.
Artemisinin was discovered in 1971 as a constituent of the wormwood genus plant (Artemisia annua). This plant has been used as an herbal medicine to treat malaria since ancient times. The compound artemisinin has a sesquiterpene lactone bearing a peroxide group that offers its biological activity. In addition to anti-malarial activity, artemisinin derivatives have been reported to exert antitumor activity in cancer cells, and have attracted attention as potential anti-cancer drugs. Mechanisms that might explain the antitumor activities of artemisinin derivatives reportedly induction of apoptosis, angiogenesis inhibitory effects, inhibition of hypoxia-inducible factor-1α (HIF-1α) activation, and direct DNA injury. Reactive oxygen species (ROS) generation is involved in many cases. However, little is known about the mechanism of ROS formation from artemisinin derivatives and what types of ROS are produced. Therefore, we investigated the iron-induced ROS formation mechanism by using artesunate, a water-soluble artemisinin derivative, which is thought to be the underlying mechanism involved in artesunate-mediated cell death. The ROS generated by the coexistence of iron(II), artesunate, and molecular oxygen was a hydroxyl radical or hydroxyl radical-like ROS. Artesunate can reduce iron(III) to iron(II), which enables generation of ROS irrespective of the iron valence. We found that reduction from iron(III) to iron(II) was activated in the acidic rather than the neutral region and was proportional to the hydrogen ion concentration.
青蒿素于1971年作为蒿属植物(青蒿)的一种成分被发现。自古以来,这种植物就被用作治疗疟疾的草药。青蒿素化合物是一种带有过氧化物基团的倍半萜内酯,具有生物活性。除抗疟活性外,据报道青蒿素衍生物在癌细胞中具有抗肿瘤活性,并作为潜在的抗癌药物受到关注。据报道,可能解释青蒿素衍生物抗肿瘤活性的机制包括诱导细胞凋亡、血管生成抑制作用、抑制缺氧诱导因子-1α(HIF-1α)激活以及直接DNA损伤。在许多情况下都涉及活性氧(ROS)的产生。然而,关于青蒿素衍生物产生ROS的机制以及产生何种类型的ROS知之甚少。因此,我们使用青蒿琥酯(一种水溶性青蒿素衍生物,被认为是青蒿琥酯介导细胞死亡的潜在机制)研究了铁诱导的ROS形成机制。铁(II)、青蒿琥酯和分子氧共存产生的ROS是羟基自由基或类似羟基自由基的ROS。青蒿琥酯可以将铁(III)还原为铁(II),无论铁的价态如何都能产生ROS。我们发现从铁(III)到铁(II)的还原在酸性区域而非中性区域被激活,并且与氢离子浓度成正比。